Schedule 13D ownership disclosure
NEWAMSTERDAM PHARMA COMPANY
Security class unavailable · CUSIP: N62509109
Event date: 2022-11-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-296700
- Form type
- SC 13D
- Filer
- Frazier Lifesciences Sponsor LLC
- CIK
- CIK 1828906
- Filed
- Dec 02, 2022
- Reporting period
- Nov 22, 2022
- Description
- Schedule 13D beneficial ownership